EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
The new GLP-1 weight-loss pill vs. the shot: A doctor’s honest answer on oral Wegovy
FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
Wait times for cancer patients’ first treatments increase: study
Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of…
‘Like the meat inside a toasted sandwich’: Nurses and doctors on working during a heatwave
UNUSUAL RASHES, FAINTING, and baking conditions. These are some of the things that doctors and nurses have seen…
Study reveals why key antiviral defenses failed in some severe COVID-19 patients
Pre-existing autoimmunity underlying susceptibility to viral infections. Credit: Cell (2026). DOI: 10.1016/j.cell.2026.04.013 Researchers find that key antiviral proteins…
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
US Nurse Fired Over Video Suggesting She Avoids Patients Watching Fox News
The University of Texas Medical Branch (UTMB) has fired a nurse after investigating a viral social media video…
Nurse banned after poor English put patients at risk
A woman was banned from working as an NHS nurse after her poor understanding of the English language…
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Eledon Pharmaceuticals, Inc. Tegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73…
‘Only death can stop me’: terminally ill Chinese tycoon works 12 hours daily to cure ALS
A former Chinese e-commerce executive in the final stages of a rare disease is still working 12-hour days,…
The new weight-loss pill vs. the shot: A doctor’s honest answer on oral Wegovy
When the FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025…
After chemo and immunotherapy fail, lung cancer drug shrinks tumors in 43% of patients
A drug already used to treat certain lung cancers is showing promising results in people with head and…